Assessment of Transporter‐Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients With Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

Assessment of Transporter‐Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients With Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Published:2021-10-27 Issue: Volume: Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Cheng Yiming¹,Wang Xiaomin²,Tong Zeen²,Reyes Josephine¹,Carayannopoulos Leon¹,Zhou Simon¹,Li Yan¹

Affiliation:

1. Clinical Pharmacology & Pharmacometrics Bristol Myers Squibb Summit New Jersey USA

2. Nonclinical Research & Development Bristol Myers Squibb Summit New Jersey USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1979

Reference28 articles.

1. Targeting the IDH2 Pathway in Acute Myeloid Leukemia

2. Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation;DiNardo C;Clin Adv Hematol Oncol,2018

3. Enasidenib for the treatment of acute myeloid leukemia

4. Development of novel therapeutics targeting isocitrate dehydrogenase mutations in cancer;Sharma H;Curr Top Med Chem,2018

5. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of CYP‐Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients with Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome;The Journal of Clinical Pharmacology;2024-04-02

2. Integrating Full Bayesian Inference and Student's t‐Distribution Method for Enhanced Outlier Handling in Caffeine Population Pharmacokinetics: Assessing Drug–Drug Interactions with Enasidenib in Relapsed or Refractory AML and MDS Patients;The Journal of Clinical Pharmacology;2024-03-13

3. Enasidenib causes clinically relevant rosuvastatin accumulation leading to toxic myopathy;2024-02-20

4. An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment;International Journal of Molecular Sciences;2023-03-23

5. Model‐based analysis for the population pharmacokinetics of iberdomide and its major active metabolite in healthy subjects and patients with relapsed and refractory multiple myeloma;British Journal of Clinical Pharmacology;2022-08-29